KUALA LUMPUR: Kenanga Investment Bank Bhd (Kenanga IB) expects the ringgit to trade closer to 4.40 by year-end, based on emerging signs which...
Vous n'êtes pas connecté
KUALA LUMPUR: Kenanga Investment Bank Bhd maintained its "outperform" rating on Karex Bhd, setting a share target price of RM1.12 after the United States Food and Drug Administration (FDA) approved its new synthetic condoms. Read full story
KUALA LUMPUR: Kenanga Investment Bank Bhd (Kenanga IB) expects the ringgit to trade closer to 4.40 by year-end, based on emerging signs which...
Drug company Indies Pharma Jamaica Limited is looking to double next year’s revenues, following approval of its abbreviated new drug application,...
KUALA LUMPUR: Shares of Poh Huat Resources Holdings Bhd slumped near its 52-week low today following dissappointing third quarter of financial year...
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....
KUALA LUMPUR: Malaysia Airlines Bhd is offering up to 30 per cent discount on airfares for its economy and business class seats on all of its flights...
KUALA LUMPUR: Hibiscus Petroleum Bhd has declared a final dividend of 1.0 sen per ordinary share for the financial year ended June 30, 2024 (FY24),...
KUALA LUMPUR: Stocks to watch on Monday include Yinson Holdings Bhd, CIMB Group Holdings Bhd, Malaysia Airports Holdings Bhd (MAHB), Malaysian...
KUALA LUMPUR: Stocks to watch on Monday include Yinson Holdings Bhd, CIMB Group Holdings Bhd, Malaysia Airports Holdings Bhd (MAHB), Malaysian...
HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...
HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...